Health Advance Announces New Management in Most Recent 10Q

HADV plans to grow having engaged new, highly credentialed executive management and advisors.

COLORADO SPRINGS, CO, June 14, 2017 /PRNewswire/ - Today Health Advance, Inc. (OTC PINK: HADV) announced new additions to the company's board and executive management team. These along with other material changes are outlined in a board resolution exhibit included with its 10-Q quarterly filing, overdue since March resulting from major changes following the license agreement and partnership with Micro Medtech Limited, a developer of organic dietary supplements and medical foods derived from botanical blends containing kava, cannabidoil (INN: CBD), and mitragyna speciosa (better known as kratom).

Not only did Health Advance appoint a new chairman of the board of directors but also a new CEO, Vice President, and an in-house certified public accountant, in addition to contracting a media relations firm in Canada.

Dr. Muhammad Mukhtar, Ph.D who will be serving as the new Secretary, (Acting) CEO, and Chief Board Advisor.

Dr. Muhammad Mukhtar Ph.D. has served as a professor at the American University of Ras Al Khaimah (AURAK), United Arab Emirates. Before his arrival at AURAK, he served as Vice Chancellor/Professor of three Universities in Pakistan concomitantly – a unique honor for any academic leader. Through his wise academic leadership and innovative governance, he converted a regional higher education institution in Pakistan to one of the top-ranked in the country. Dr. Mukhtar received his Masters and MPhil in the field of Biochemistry from Pakistan and his Ph.D. in biosciences from the Drexel University of Philadelphia, USA, and also completed a Graduate Certificate in Research Management from Thomas Jefferson University in Philadelphia, USA. He served in various academic/administrative positions in the USA on an outstanding scientist (O-1) visa.

Dr. Mukhtar is also an avid researcher. His laboratory developed an in-vitro model of the human blood-brain barrier to study viral neuropathogenesis. Dr. Mukhtar as Principal or Co-Investigator has received several awards from organizations including American Diabetes Association, American Society for Microbiology, Diabetes Trust Foundation, US National Institutes of Health, Pfizer Pharmaceuticals (NYSE: PFE), and the Higher Education Commission of Pakistan. Human blood-brain barrier model developed in his laboratory is extensively used to understand ferrying of viruses into the brain and finding cures for neurological ailments.

Dr. Mukhtar holds specialized Certificates in Public Health and Bioinformatics. Committed to the role of technology in biomedical research, he serves as managing editor of Frontiers in Bioscience and is on the editorial board of several research journals. He feels pride in mentoring researchers, scientists, teachers and administrators and committed professionals aspiring to excel in their practical life. He has several research publications, including peer-reviewed research, review articles, invited articles, book chapters, commissioned articles and critiques to his credit. A book describing accomplishments of Dr. Mukhtar's educational leadership has been published in Urdu language entitled "Hayat Zauq e Safar Kay Siwa Kuch Aur Naheen" and it's English Version "The Making of a Best National University" is in progress.

Dr. Hauke Kolster, Ph.D. will serve as the company's new Vice President.

Dr. Kolster is an innovative scientist and engineer with outstanding quantitative and analytical skills. Technically versed professional with progressive experience in coordinating projects as well as working in cross-functional teams in multiple disciplines. A goal oriented individual who excels in problem-solving and managing complex projects with strict timelines amid multiple stakeholders.

Since 2012 Dr. Kolster has owned and operated Windmiller Kolster Scientific in California offering scientific and research consulting, technology and software for the neuroimaging sector. Supported leading neuroscientific research groups at top domestic and international universities. Previously Dr. Kolster served as a Research Assistant Professor at KU Leuven Medical School (Leuven) and Research Assistant Professor at Department of Neuroscience since 2007.

Dr. Kolster's professional training includes research fellowship program at Harvard Medical School, in addition to working as a senior post-doctoral associate at Massachusetts Institute of Technology at Cambridge.

Dr. Kolster studied and graduated at LMU Munich, Munich for his Ph.D. and Bonn University (Bonn, Germany) for a master's degree in physics.

These new management selections are just the beginning of changes the company announced in its recent SEC and State of Wyoming filings. The company has moved from Las Vegas to a new physical office location in Colorado Springs. The company also plans to file SEC Forms S-3 and S-6 registration statements to secure payments for related investments in the company and to inform investors about major changes. The company has been trading on the PINKS but has decided to apply for acceptance onto the OTCQB exchange.

About Health Advance

Health Advance, Inc. is a publicly traded Wyoming corporation that develops, manufacturers, and distributions cost-effective dietary supplements and medical foods from organic sources that contain botanical extract blends as an alternative to synthetic drugs and herbal supplements, in efforts to treat pain, cancer, opiates/alcohol withdrawal, epilepsy, PTSD, and other severe illnesses.

For more information about Health Advance go to www.hadvinc.com, or go to their one-minute company overview video clip on YouTube.

SOURCE Health Advance Inc.